Generative AI in Pharmaceutical Market
According to Intent Market Research, the Generative AI In Pharmaceutical Market is expected to grow from USD 2.4 billion in 2024-e at a CAGR of 55.8% to touch USD 53.7 billion by 2030. The Generative AI In Pharmaceutical Market is dominated by key players such as IBM, Microsoft Corporation, Google DeepMind, NVIDIA Corporation, Moderna Inc., Roche Pharmaceuticals, Pfizer Inc., Sanofi S.A., GlaxoSmithKline plc, AstraZeneca, Merck & Co., Bayer AG, Novartis International AG, Johnson & Johnson, AbbVie Inc.